SCHEMBL2985403

SCHEMBL2985403

CCOC(C(=O)O)C(O)CC

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 1/20 0.32
MMP2 P08253 1/20 0.32
MMP3 P08254 1/20 0.32
MMP9 P14780 1/20 0.32
MMP13 P45452 1/20 0.32
SLC1A3 P43003 4/20 0.32
SLC1A2 P43004 4/20 0.32
SLC1A1 P43005 4/20 0.32
TP53 P04637 1/20 0.32
THRB P10828 1/20 0.32
PGD P52209 1/20 0.32
CA2 P00918 1/20 0.31
MAPK1 P28482 1/20 0.31
PPARA Q07869 3/20 0.31
CHRM1 P11229 1/20 0.31
AKR1A1 P14550 1/20 0.31
CHRM3 P20309 1/20 0.31
HTR2A P28223 1/20 0.31
HTR2C P28335 1/20 0.31
ADRA1A P35348 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL387178 0.83 THRB (0.40) MMP1MMP2MMP3MMP9MMP13
SCHEMBL1160265 0.83 THRB (0.40) MMP1MMP2MMP3MMP9MMP13
SCHEMBL1196063 0.83 THRB (0.40) MMP1MMP2MMP3MMP9MMP13
SCHEMBL2963336 0.79 TSHR (0.41) MMP1MMP2MMP3MMP9MMP13
SCHEMBL2849502 0.79 SLC1A3 (0.48) MMP1MMP2MMP3MMP9MMP13
SCHEMBL26940426 0.77 ALDH1A1 (0.38) MMP1MMP2MMP3MMP9MMP13
SCHEMBL8085167 0.77 ALDH1A1 (0.38) MMP1MMP2MMP3MMP9MMP13
SCHEMBL11382908 0.77 TDP1 (0.36) MMP1MMP2MMP3MMP9MMP13
SCHEMBL7582653 0.77 GPR84 (0.44) TP53
SCHEMBL7582656 0.77 GPR84 (0.44) TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10551566-B2 Method of preparing an optical connector and optical devices comprising the optical connector prepared thereby DOW SILICONES CORPORATION (US) 2020-02-04 US disclosed
US-10435585-B2 Curable composition, method of preparing cured article, and cured article formed thereby DOW CORNING CORPORATION (US) 2019-10-08 US disclosed
EP-2996867-B1 METHOD OF PREPARING AN ARTICLE AND ARTICLE PREPARED THEREBY DOW SILICONES CORP (US) 2018-09-19 EP disclosed
EP-3164449-A1 METHODS FOR PREPARING ARTICLES AND ASSOCIATED ARTICLES PREPARED THEREBY Dow Corning Corporation (US) 2017-05-10 EP disclosed
US-20170107331-A1 Methods For Preparing Articles And Associated Articles Prepared Thereby DOW CORNING CORPORATION (US) 2017-04-20 US disclosed
US-20160349455-A1 METHOD OF PREPARING AN OPTICAL CONNECTOR AND OPTICAL DEVICES COMPRISING THE OPTICAL CONNECTOR PREPARED THEREBY DOW SILICONES CORPORATION 2016-12-01 US disclosed
US-20160102226-A1 Curable Composition, Method Of Preparing Cured Article, And Cured Article Formed Thereby DOW SILICONES CORPORATION 2016-04-14 US disclosed
EP-2996867-A1 METHOD OF PREPARING AN ARTICLE AND ARTICLE PREPARED THEREBY Dow Corning Corporation (US) 2016-03-23 EP disclosed
EP-2997101-A1 CURABLE COMPOSITION, METHOD OF PREPARING CURED ARTICLE, AND CURED ARTICLE FORMED THEREBY Dow Corning Corporation (US) 2016-03-23 EP disclosed
US-20160077279-A1 Method of Preparing an Article and Article Prepared Thereby DOW SILICONES CORPORATION 2016-03-17 US disclosed
WO-2016003636-A1 METHODS FOR PREPARING ARTICLES AND ASSOCIATED ARTICLES PREPARED THEREBY DOW CORNING CORPORATION (US) 2016-01-07 WO disclosed
WO-2014186549-A1 METHOD OF PREPARING AN ARTICLE AND ARTICLE PREPARED THEREBY DOW CORNING CORPORATION (US) 2014-11-20 WO disclosed
WO-2014186514-A1 CURABLE COMPOSITION, METHOD OF PREPARING CURED ARTICLE, AND CURED ARTICLE FORMED THEREBY DOW CORNING CORPORATION (US) 2014-11-20 WO disclosed
EP-1692209-B1 ACTIVE ENERGY RAY-CURABLE ORGANOPOLYSILOXANE RESIN COMPOSITION, LIGHT-TRANSMITTING COMPONENT, AND METHOD FOR MANUFACTURING THE LIGHT-TRANSMITTING COMPONENT DOW CORNING TORAY CO LTD (JP) 2013-10-02 EP disclosed
US-7771794-B2 Active energy ray-curable, organopolysiloxane resin composition, light-transmitting component, and method for manufacturing the light-transmitting component DOW CORNING CORPORATION (US) 2010-08-10 US disclosed
US-20080058441-A1 Active Energy Ray-Curable, Organopolysiloxane Resin Composition, Light-Transmitting Component, And Method For Manufacturing The Light-Transmitting Component DOW TORAY CO., LTD. (JP) 2008-03-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10435585-B2 Curable composition, method of preparing cured article, and cured article formed thereby SETDB1, SETD2, SETD1A MMP1 2637/4885MMP2 3938/4885MMP3 4156/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.